Brief: Procept Biorobotics Q4 Net Income USD -29.845 Million
25/02/2026 21:02
Feb 25 (Reuters) - Procept Biorobotics Q4 revenue USD 76.383 million vs. IBES estimate USD 94.1 million. Q4 adjusted EBITDA USD -19.013 million vs. IBES estimate USD -2.8 million outlook FY revenue USD 390-410 million outlook FY gross margin 65% outlook FY revenue growth 27-33% outlook FY adjusted EBITDA USD -30 to -17 million
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc